NCT07229417
- Conditions
- Metastatic Endocrine Refractory, Triple Negative Invasive Lobular Carcinoma
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Triple Negative Invasive Lobular Carcinoma
Explore clinical trials studying Triple Negative Invasive Lobular Carcinoma. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study